1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "2252395-44-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-126147

    HDAC Cancer
    J22352 is a PROTAC (proteolysis-targeting chimeras)-like and highly selective HDAC6 inhibitor with an IC50 value of 4.7 nM. J22352 promotes HDAC6 degradation and induces anticancer effects by inhibiting autophagy and eliciting the antitumor immune response in glioblastoma cancers, and leading to the restoration of host antitumor activity by reducing the immunosuppressive activity of PD-L1.